Justin D. Gover, Chief Executive Officer at GW PHARMACEUTICALS PLC (GWPH), sold 22,128 shares at $12.45 ($275K) on 2019-02-26, disclosed to the SEC on 2019-02-28.
Open-market sale of $275k GWPH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.28 | 96 | $1K | 0.4% |
| 2 | $12.45 | 11,016 | $137K | 49.8% |
| 3 | $12.45 | 11,016 | $137K | 49.8% |
| Total | $12.45 avg | 22,128 | $275K | 100% |
| Filing → |
| GWPH | SELL | 2020-03-04 | $477K | — | Filing → |
| GWPH | SELL | 2020-02-28 | $194K | — | Filing → |
| GWPH | SELL | 2020-02-05 | $3.9M | — | Filing → |